Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Billionaire Ken Griffin Says Trump's Tariffs Have Made the U.S. "20% Poorer." Here's What You Can Do to Prevent Further Wealth Erosion.
Billionaire Ken Griffin Says Trump's Tariffs Have Made the U.S. "20% Poorer." Here's What You Can Do to Prevent Further Wealth Erosion.

Billionaire Ken Griffin is a major supporter of President Donald Trump and donated $100 million last year to conservative groups. However, Griffin isn't a fan of all the president's policies.

He

Up Over 60% in the Past Year, Is It Too Late to Buy AT&T Stock?
Up Over 60% in the Past Year, Is It Too Late to Buy AT&T Stock?

AT&T (NYSE: T) is a leading telecom company in the country -- and as it has exited the streaming and media businesses and refocused on its core operations, it has been proving to be a solid

AT&T Stock Is Back to Multiyear Highs. Time to Buy?
AT&T Stock Is Back to Multiyear Highs. Time to Buy?

AT&T (NYSE: T) stock appears to be benefiting from its most promising outlook in years. Earlier in the decade, the stock suffered after the company slashed its dividend in 2022 following 35

Why Biotech Stars Summit Therapeutics and BioNTech Plunged, Even as This Chinese Rival Surged Today
Why Biotech Stars Summit Therapeutics and BioNTech Plunged, Even as This Chinese Rival Surged Today

Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the place on Friday. Both U.S.-based Summit Therapeutics (NASDAQ: SMMT) and

According to This Critical Number, AT&T's 4%-Yielding Dividend is Now on Rock-Solid Ground
According to This Critical Number, AT&T's 4%-Yielding Dividend is Now on Rock-Solid Ground

There have been a lot of questions surrounding AT&T's (NYSE: T) dividend in recent years. The telecom giant already cut its payout by nearly 50% in 2022 to retain additional cash for debt reduction

AT&T Shows No Sign of Slowing Down
AT&T Shows No Sign of Slowing Down

While fellow telecom giant Verizon is struggling with subscriber losses, AT&T (NYSE: T) put up strong numbers in its first-quarter report Wednesday morning. Postpaid phone net adds topped 300,000

Why AT&T Stock Lagged the Market Today
Why AT&T Stock Lagged the Market Today

The stock market was in rally mode on Wednesday, but you wouldn't know it from AT&T's (NYSE: T) performance. Investors reacted to the company's latest set of quarterly earnings but traded the stock

Why Summit Therapeutics Rocketed Double-Digits Today
Why Summit Therapeutics Rocketed Double-Digits Today

Shares of lung cancer biotech Summit Therapeutics (NASDAQ: SMMT) rocketed 14.7% on Wednesday as of 1:45 p.m. ET.

The markets were broadly up today on a potential easing of trade tensions with China

Why AMD, Broadcom, and Taiwan Semiconductor Manufacturing Stocks Rallied on Wednesday
Why AMD, Broadcom, and Taiwan Semiconductor Manufacturing Stocks Rallied on Wednesday

The uncertainty that has gripped the market recently has been palpable. Concerns about the on-again, off-again tariffs, a high-profile spat between the White House and the Federal Reserve Bank, and

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Growth investors feast on volatility, but the turbulence has proved challenging for Cathie Wood. The founder and CEO of Ark Invest has taken a hit in the current climate. Her largest exchange-traded

AT&T Surpasses Q1 Revenue Estimates
AT&T Surpasses Q1 Revenue Estimates

Telecommunications giant AT&T (NYSE:T) reported fiscal 2025 first quarter earnings on Wednesday, April 23, that matched or exceeded analysts' consensus expectations. Revenue of $30.63 billion came

This Company's Co-CEOs Just Bought More Shares. Should You?
This Company's Co-CEOs Just Bought More Shares. Should You?

Nobody has more information about a company than its insiders, especially its executive management team. That's why when one of them buys more shares, it sometimes gives individual investors

Wall Street Sees 48% or More Upside for These AI Stocks. Should You Buy Them?
Wall Street Sees 48% or More Upside for These AI Stocks. Should You Buy Them?

There's a lot of optimism on the long-term prospects of leading semiconductor makers. Big tech companies investing in artificial intelligence (AI) are requiring constant innovation in chip

Nvidia Stock: The Week of April 14-18 in Review
Nvidia Stock: The Week of April 14-18 in Review

Shares of Nvidia (NASDAQ: NVDA), the leading maker of artificial intelligence (AI) chips, dropped 8.5% last week, which was a four-day trading week due to the stock market being closed for the Good

Is AMD Stock a Buy Before Its June Artificial Intelligence (AI) Event?
Is AMD Stock a Buy Before Its June Artificial Intelligence (AI) Event?

In today's video, I discuss Advanced Micro Devices (NASDAQ: AMD) and recent updates affecting the semiconductor market. To learn more, check out the short video, consider subscribing, and click the

3 Artificial Intelligence Stocks to Buy Before the Market Recovers
3 Artificial Intelligence Stocks to Buy Before the Market Recovers

The stock market has been volatile this year, and it's anyone's guess how things will continue to play out. If there's a recession, then the S&P 500 and stocks as a whole could be headed for even

Better Artificial Intelligence Stock: AT&T vs. SoundHound AI
Better Artificial Intelligence Stock: AT&T vs. SoundHound AI

Technology routinely affects nearly every part of the economy. In other words, companies that aren't traditional technology stocks can benefit from artificial intelligence (AI).

U.S

2 Dividend Stocks to Double Up on Right Now
2 Dividend Stocks to Double Up on Right Now

Dividend stocks are the best antidote for market volatility. There's nothing like seeing quarterly cash deposits in your account from industry-leading businesses. With the S&P 500 (SNPINDEX: ^GSPC)

Great News for AMD Stock Investors
Great News for AMD Stock Investors

In this video, I go over recent updates regarding Advanced Micro Devices (NASDAQ: AMD). Watch the short video to learn more, consider subscribing, and click the special offer link below.

*Stock

Aswath Damodaran on Investing in Uncertainty
Aswath Damodaran on Investing in Uncertainty

Aswath Damodaran teaches corporate finance and valuation at the Stern School of Business at New York University. In this podcast, Motley Fool Senior Analyst Matt Argersinger caught up with Damodaran

What Nvidia, AMD, and Intel Stock Investors Should Know About Recent Updates
What Nvidia, AMD, and Intel Stock Investors Should Know About Recent Updates

In today's video, I discuss Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), Intel (NASDAQ: INTC), other technology stocks, and recent updates affecting the semiconductor market. To

EQS-Adhoc: Heidelberg Pharma AG: Heidelberg Pharma Determines Recommended Dose for Phase II Trial with ADC Candidate HDP-101
EQS-Adhoc: Heidelberg Pharma AG: Heidelberg Pharma Determines Recommended Dose for Phase II Trial with ADC Candidate HDP-101
EQS-Adhoc: Heidelberg Pharma AG: Heidelberg Pharma Determines Recommended Dose for Phase II Trial with ADC Candidate HDP-101
EQS-News: Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
EQS-News: Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
EQS-News: Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
Uni-Bio Science Group Limited Announces 2025 Annual Results
Uni-Bio Science Group Limited Announces 2025 Annual Results
Uni-Bio Science Group Limited Announces 2025 Annual Results
EQS-News: Heidelberg Pharma Announces Financial Figures and Reports on Business Performance in 2025 and Outlook for 2026
EQS-News: Heidelberg Pharma Announces Financial Figures and Reports on Business Performance in 2025 and Outlook for 2026
EQS-News: Heidelberg Pharma Announces Financial Figures and Reports on Business Performance in 2025 and Outlook for 2026